Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
32-33
|
pubmed:dateCreated |
1983-12-17
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0341-3098
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
22
|
pubmed:volume |
125
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
715-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6138710-Anti-Anxiety Agents,
pubmed-meshheading:6138710-Bromazepam,
pubmed-meshheading:6138710-Clorazepate Dipotassium,
pubmed-meshheading:6138710-Double-Blind Method,
pubmed-meshheading:6138710-Humans,
pubmed-meshheading:6138710-Middle Aged,
pubmed-meshheading:6138710-Psychophysiologic Disorders
|
pubmed:year |
1983
|
pubmed:articleTitle |
[Therapy of psychoautonomic disorders. Clinical double-blind duplex study with dipotassium chlorazepate and bromazepam].
|
pubmed:publicationType |
Journal Article,
Comparative Study
|